Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Glioblastoma 7Recurrence 2Prostatic Neoplasms 2Brain Neoplasms 2Astrocytoma 2Optic Nerve Glioma 1Oligodendroglioma 1Metatropic dwarfism 1Melanoma 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Gliosarcoma 1Glioma 1Diffuse Intrinsic Pontine Glioma 1Congenital Abnormalities 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cytarabine 23Busulfan 12Peripheral Blood Stem Cell Transplantation 11Cyclophosphamide 10fludarabine phosphate 9Filgrastim 9Cyclosporine 9Antilymphocyte Serum 9Idarubicin 8Methotrexate 7sargramostim 6Mitoxantrone 6Gemtuzumab 6Etoposide 6Daunorubicin 6Radiotherapy 5tipifarnib 4Whole-Body Irradiation 4alvocidib 3Vorinostat 3Tacrolimus 3Mycophenolic Acid 3Methylprednisolone 3Flow Cytometry 3Cytogenetic Analysis 3Cyclosporins 3Clofarabine 3Azacitidine 3merphos 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Megakaryoblastic, Acute × Cilengitide × Clear all
NCT00089388 2013-01-24

Cilengitide in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Terminated
70 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡